Clinical Cardiology Alert – October 1, 2004
October 1, 2004
View Issues
-
Prevention of Atrial Fibrillation After Cardioversion
The Prevention of Atrial Fibrillation After Cardioversion Trial was a placebo-controlled study comparing sotalol and a quinidine/verapamil combination in patients with persistent atrial fibrillation after cardioversion. -
Warfarin vs Aspirin for Bioprosthetic Aortic Valve Replacement
Low-dose aspirin is as effective as warfarin for preventing cerebral thromboembolic events after bioprosthetic aortic valve replacement. -
Public-Access Defibrillation
The use of automatic external defibrillators by trained volunteers is safe and effective, particularly in public locations where there is at least a moderate likelihood that an out-of-hospital cardiac arrest will be witnessed. -
Relationship Between Calcium Scans and Stress Myocardial Perfusion
A calcium score < 100 eliminates the need for myocardial perfusion scans (MPS), but patients with a negative MPS often have coronary calcium. These findings imply a potential role for applying coronary artery calcium screening after MPS among patients manifesting normal MPS. -
Cardiovascular Disease Trends: United States and Worldwide
The developing world is experiencing an epidemic of CAD which expects to continue to increase in the foreseeable future. -
Correction
Issues July, August, and September 2004 were printed as Volume 21. They should read Volume 23. -
Pharmacology Watch: Linking COX-2 Inhibitors and Cardiovascular Event Risk
A new, and as of yet unpublished study, has raised increased concern about the relationship between rofecoxib (Vioxx), Mercks blockbuster COX-2 inhibitor, and cardiovascular events. The study, which was presented at a meeting in Bordeaux France, was financed by the FDA in collaboration with Californias HMO giant Kaiser Permanente. -
Clinical Briefs in Primary Care Supplement